|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/22 | (2006.01) |
| A61P 9/04 | (2006.01) |
| (11) | Number of the document | 2510942 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12156696.2 |
| Date of filing the European patent application | 2006-04-07 | |
| (97) | Date of publication of the European application | 2012-10-17 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-02 |
| (46) | Date of publication of the claims translation | 2016-01-11 |
| (30) | Number | Date | Country code |
| 669751 P | 2005-04-08 | US | |
| 669786 P | 2005-04-07 | US | |
| 732585 P | 2005-11-01 | US |
| (72) |
Mitrovic, Veselin, DE
Lüss, Hartmut, DE
Forssmann, Wolf-Georg, DE
Meyer, Markus, DE
Döhler, Klaus-Dieter, DE
|
| (73) |
Cardiorentis AG,
Steinhauser Str. 74, 6300 Zug,
CH
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Natriuretinio peptido panaudojimas širdies nepakankamumo gydymui |
| Use of natriuretic peptide for treating heart failure |
| Payment date | Validity (years) | Amount | |
| 2017-05-30 | 12 | 433.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-04-07 |